The increased prostate cancer cell nuclear c-Rel and NF-κB p65 expression in clinically advanced prostate cancer tissues where increased macrophage counts and CCL2 expression have been observed further supports the role of NF-κB activity in prostate cancer progression [15,40,45]. This evidence concerns the gene NFKB1 and prostate cancer.